Device
Imagio OA/US
Imagio OA/US is a medical device with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
terminated125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completed
CONFIDENCE Registry
NCT05084729
completednot_applicable
OA for Breast Cancer NAC Response
NCT05337280
terminatednot_applicable
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
NCT03032198
completednot_applicable
IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO)
NCT02364388
Clinical Trials (4)
Showing 4 of 4 trials
NCT05084729
CONFIDENCE Registry
NCT05337280Not Applicable
OA for Breast Cancer NAC Response
NCT03032198Not Applicable
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
NCT02364388Not Applicable
IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO)
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4